Skip to main content
. 2017 Oct 25;15(1):75–84. doi: 10.3892/etm.2017.5375

Figure 5.

Figure 5.

Inhibition of FGF21 in DCM mice resulted in reduced PGC-1α and enhanced CD36 levels. (A) Western blot analysis of the expression levels of PGC-1α and CD36 in the various treatment groups. The quantified levels of (B) PGC-1α and (C) CD36 are also presented. *P<0.05. PGC-1α, peroxisome proliferator-activated receptor γ co-activator 1α; FGF21, fibroblast growth factor 21; N, normal; DCM, diabetic cardiomyopathy; Scsi, scrambled siRNA; FGF21si, FGF21 siRNA.